262 related articles for article (PubMed ID: 17448770)
1. The initial experience of antithrombin III in the management of neonates with necrotizing enterocolitis.
St Peter SD; Little DC; Calkins CM; Holcomb GW; Snyder CL; Ostlie DJ
J Pediatr Surg; 2007 Apr; 42(4):704-8. PubMed ID: 17448770
[TBL] [Abstract][Full Text] [Related]
2. Effects of recombinant human soluble thrombomodulin (rhs-TM) on a rat model of disseminated intravascular coagulation with decreased levels of plasma antithrombin III.
Aoki Y; Ohishi R; Takei R; Matsuzaki O; Mohri M; Saitoh K; Gomi K; Sugihara T; Kiyota T; Yamamoto S
Thromb Haemost; 1994 Apr; 71(4):452-5. PubMed ID: 8052962
[TBL] [Abstract][Full Text] [Related]
3. Antithrombin III administration in neonates with congenital diaphragmatic hernia during the first three days of extracorporeal membrane oxygenation.
Perry R; Stein J; Young G; Ramanathan R; Seri I; Klee L; Friedlich P
J Pediatr Surg; 2013 Sep; 48(9):1837-42. PubMed ID: 24074654
[TBL] [Abstract][Full Text] [Related]
4. Association of necrotizing enterocolitis with elective packed red blood cell transfusions in stable, growing, premature neonates.
Mally P; Golombek SG; Mishra R; Nigam S; Mohandas K; Depalhma H; LaGamma EF
Am J Perinatol; 2006 Nov; 23(8):451-8. PubMed ID: 17009195
[TBL] [Abstract][Full Text] [Related]
5. The clinical significance of thrombocytopenia in neonates with necrotizing enterocolitis.
Ververidis M; Kiely EM; Spitz L; Drake DP; Eaton S; Pierro A
J Pediatr Surg; 2001 May; 36(5):799-803. PubMed ID: 11329593
[TBL] [Abstract][Full Text] [Related]
6. [The effect of antithrombin iii concentrations during cardiopulmonary surgery].
Sonzogni V; Bellavita P; Carrara B; Cossolini M; Ferri F; Fabretti F; Mamprin F; Pelliccioli I
Minerva Anestesiol; 2000; 66(1-2):17-23. PubMed ID: 10736978
[TBL] [Abstract][Full Text] [Related]
7. Study of protein C, protein S, and antithrombin III in hypoxic newborns.
El Beshlawy A; Hussein HA; Abou-Elew HH; Abdel Kader MS
Pediatr Crit Care Med; 2004 Mar; 5(2):163-6. PubMed ID: 14987347
[TBL] [Abstract][Full Text] [Related]
8. High dose of intravenous antithrombin III without heparin in the treatment of disseminated intravascular coagulation and organ failure in four children.
Fuse S; Tomita H; Yoshida M; Hori T; Igarashi C; Fujita S
Am J Hematol; 1996 Sep; 53(1):18-21. PubMed ID: 8813091
[TBL] [Abstract][Full Text] [Related]
9. Early enteral feeding in conservatively managed stage II necrotizing enterocolitis is associated with a reduced risk of catheter-related sepsis.
Brotschi B; Baenziger O; Frey B; Bucher HU; Ersch J
J Perinat Med; 2009; 37(6):701-5. PubMed ID: 19678734
[TBL] [Abstract][Full Text] [Related]
10. [Purpura fulminans in the newborn. Report of two cases successfully treated with heparin and antithrombin III].
Ficuccilli F; Iacobini M; Beglieri MR; Papoff P; Mancuso M; Caradonna A; Donato AI; Colarizi P
Minerva Pediatr; 1997 Dec; 49(12):571-7. PubMed ID: 9577159
[TBL] [Abstract][Full Text] [Related]
11. State-based analysis of necrotizing enterocolitis outcomes.
Guner YS; Friedlich P; Wee CP; Dorey F; Camerini V; Upperman JS
J Surg Res; 2009 Nov; 157(1):21-9. PubMed ID: 19615694
[TBL] [Abstract][Full Text] [Related]
12. Platelet transfusions in infants with necrotizing enterocolitis do not lower mortality but may increase morbidity.
Kenton AB; Hegemier S; Smith EO; O'Donovan DJ; Brandt ML; Cass DL; Helmrath MA; Washburn K; Weihe EK; Fernandes CJ
J Perinatol; 2005 Mar; 25(3):173-7. PubMed ID: 15578029
[TBL] [Abstract][Full Text] [Related]
13. Impact of withdrawing antithrombin III administration from management of septic patients with or without disseminated intravascular coagulation.
Kawano S; Uchino S; Endo A; Saito K; Iwai K; Kase Y; Takinami M
Blood Coagul Fibrinolysis; 2014 Dec; 25(8):795-800. PubMed ID: 24806318
[TBL] [Abstract][Full Text] [Related]
14. Clinical parameters do not adequately predict outcome in necrotizing enterocolitis: a multi-institutional study.
Moss RL; Kalish LA; Duggan C; Johnston P; Brandt ML; Dunn JC; Ehrenkranz RA; Jaksic T; Nobuhara K; Simpson BJ; McCarthy MC; Sylvester KG
J Perinatol; 2008 Oct; 28(10):665-74. PubMed ID: 18784730
[TBL] [Abstract][Full Text] [Related]
15. Antithrombin III in Sepsis. New evidences and open questions.
Ostermann H
Minerva Anestesiol; 2002 May; 68(5):445-8. PubMed ID: 12029261
[TBL] [Abstract][Full Text] [Related]
16. Double-blind, placebo-controlled trial of antithrombin III concentrates in septic shock with disseminated intravascular coagulation.
Fourrier F; Chopin C; Huart JJ; Runge I; Caron C; Goudemand J
Chest; 1993 Sep; 104(3):882-8. PubMed ID: 8365305
[TBL] [Abstract][Full Text] [Related]
17. Antithrombin III concentrates for treatment of disseminated intravascular coagulation in children.
Hanada T; Abe T; Takita H
Am J Pediatr Hematol Oncol; 1985; 7(1):3-8. PubMed ID: 4037242
[TBL] [Abstract][Full Text] [Related]
18. [Treatment effects of antithrombin-III on coagulation abnormalities in rats with endotoxaemia].
Qiao YJ; Zhu JM; You XL; Zhang Y
Zhongguo Wei Zhong Bing Ji Jiu Yi Xue; 2007 Mar; 19(3):165-7. PubMed ID: 17376272
[TBL] [Abstract][Full Text] [Related]
19. [Place of antithrombin III concentrate in the intensive care of disseminated intravascular coagulation].
Vorob'eva NA; Neporada EL; Turundaevskaia OV; Mel'nikova GN
Anesteziol Reanimatol; 2007; (2):42-4. PubMed ID: 17563999
[TBL] [Abstract][Full Text] [Related]
20. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
